CLINICAL TRIALS PROFILE FOR ATROPEN
✉ Email this page to a colleague
All Clinical Trials for ATROPEN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00947596 ↗ | A Study of Inhaled Atropine Sulfate in Healthy Adults | Completed | U.S. Army Space and Missile Defense Command | Phase 1 | 2009-08-01 | MicroDose Defense Products, LLC is developing an atropine dry powder inhaler (ADPI). This pilot study compares the pharmacokinetics (PK) of inhaled dry powder atropine as delivered by the ADPI to atropine delivery from the AtroPen autoinjector. |
| NCT00947596 ↗ | A Study of Inhaled Atropine Sulfate in Healthy Adults | Completed | University of Pittsburgh | Phase 1 | 2009-08-01 | MicroDose Defense Products, LLC is developing an atropine dry powder inhaler (ADPI). This pilot study compares the pharmacokinetics (PK) of inhaled dry powder atropine as delivered by the ADPI to atropine delivery from the AtroPen autoinjector. |
| NCT00947596 ↗ | A Study of Inhaled Atropine Sulfate in Healthy Adults | Completed | MicroDose Defense Products L.L.C. | Phase 1 | 2009-08-01 | MicroDose Defense Products, LLC is developing an atropine dry powder inhaler (ADPI). This pilot study compares the pharmacokinetics (PK) of inhaled dry powder atropine as delivered by the ADPI to atropine delivery from the AtroPen autoinjector. |
| NCT01191398 ↗ | Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation | Completed | Craig J. Huang | N/A | 2010-06-01 | The purpose of this study is to determine if the antisialagogues (anti-salivary agents), Atropine and Glycopyrrolate, are effective in reducing hypersalivation when sedating patients with Ketamine for procedural sedation in the emergency department or abscess clinic. The investigators will measure salivary flow rate by collecting oral secretions by oral suctioning over a 30 minute time period starting with the administration of Ketamine. The investigators hypothesize that patients who receive either atropine or glycopyrrolate will have fewer oral secretions than patients who receive placebo. |
| NCT01595399 ↗ | Atropine Versus no Atropine for Neonatal Rapid Sequence Intubation | Unknown status | University of Manitoba | Phase 4 | 2012-04-01 | The purpose of this study is to compare heart rate in infants who receive atropine as a part of their medication before intubation to those who do not. To be able to find out , we need to divided babies into 2 groups; group 1 : receives atropine + sedation + muscle relaxant group 2 : receives water or saline ( placebo group) + sedation + muscle relaxant Then we need to compare heart rate during intubation and duration of intubation between the 2 groups. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ATROPEN
Condition Name
Clinical Trial Locations for ATROPEN
Trials by Country
Clinical Trial Progress for ATROPEN
Clinical Trial Phase
Clinical Trial Sponsors for ATROPEN
Sponsor Name
